COVID-19 Clinical Trials in Chicago

Showing 101-120 of 145 trials

Study to Evaluate the Safety and Efficacy of High Dose Intravenous Immune Globulin (IVIG) Plus Standard Medical Treatment (SMT) Versus SMT Alone in Participants in Intensive Care Unit (ICU) With Coronavirus Disease (COVID-19)

NCT04480424

The purpose of the study is to determine if a high dose of Intravenous Immune Globulin (IVIG) plus Standard Medical Treatment (SMT) can reduce all-cause mortality versus SMT alone in hospitalized participants with COVID-19 requiring admission to the ICU through Day 29.

COVID-19

Grifols Therapeutics LLC100 participantsStarted Sep 2020

Chandler, Arizona, United States • Coronado, California, United States • Chicago, Illinois, United States +15 more locations

TERMINATEDPhase 2/32.2 miles

Treatment for COVID-19 in High-Risk Adult Outpatients

NCT04354428

This is a randomized trial for the treatment of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection in high-risk adults not requiring hospital admission.The overarching goal of this study is to assess the effectiveness of interventions on the incidence of lower respiratory tract infection (LRTI) progression among high-risk adult outpatients with SARS-CoV-2 infection to inform public health control strategies.

COVID-19SARS-CoV-2

University of Washington289 participantsStarted Apr 2020

Chicago, Illinois, United States • New Orleans, Louisiana, United States • Boston, Massachusetts, United States +3 more locations

Study to Evaluate the Safety and Efficacy of High Dose Intravenous Immune Globulin (IVIG) Plus Standard Medical Treatment (SMT) Versus SMT Alone in Participants in Intensive Care Unit (ICU) With Coronavirus Disease (COVID-19)

Treatment for COVID-19 in High-Risk Adult Outpatients

COVID-19 Trials in Other Cities

Study of Multiple Candidate Agents for the Treatment of COVID-19 in Hospitalized Patients

Tocilizumab to Prevent Clinical Decompensation in Hospitalized, Non-critically Ill Patients With COVID-19 Pneumonitis

Dapagliflozin in Respiratory Failure in Patients With COVID-19

Convalescent Plasma to Stem Coronavirus (CSSC-001)

A Study to Investigate Intravenous Tocilizumab in Participants With Moderate to Severe COVID-19 Pneumonia

COVID-19 Progression in End-Stage Kidney Disease

A Study of Opaganib in Coronavirus Disease 2019 Pneumonia

A Phase 3 Study to Evaluate the Safety, Tolerability, and Immunogenicity of Multiple Production Lots and Dose Levels of BNT162b2 RNA-Based COVID-19 Vaccines Against COVID-19 in Healthy Participants

Sotrovimab Expanded Access Treatment Protocol (COVID-19)

InterLeukin-7 to Improve Clinical Outcomes in Lymphopenic pAtients With COVID-19 Infection ( ILIAD-7-US-I )

Inpatient Treatment of COVID-19 With Anti-Coronavirus Immunoglobulin (ITAC)

A Study of Immune Responses to the Virus That Causes COVID-19

Medical Masks vs N95 Respirators for COVID-19

COVID-19 Vaccines Safety Tracking (CoVaST)

Study of the Efficacy and Safety of STI-5656 (Abivertinib Maleate) in Subjects Hospitalized With COVID-19

Safety, Tolerability, and Pharmacokinetics of SAB-185 in Healthy Participants

Prone Positioning Short-term Effects on Tissue Oxygen Saturation in Critical COVID-19 Patients

Coronavirus Disease (COvid-)19 REgistry on THROMBOSIS Complications

Other Conditions in Chicago